Abstract
DCB treatment for infrapopliteal atherosclerotic arteries produced equally safe results at 1 month and a statistically significant improvement in the primary efficacy end point when compared with non-DCB at 6 months.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
